10th International Congress on the Future of Breast Cancer  

July 7-10, 2011 | Hotel del Coronado | Coronado, CA

The 10th International Congress on the Future of Breast Cancer is an educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed, and controversial issues will be debated. In addition, strategies for optimizing the use of endocrine therapy, conventional chemotherapy, and targeted therapies will be presented, and evolving diagnostic approaches to identify the driving mutations or pathways in breast cancer will be thoroughly discussed along with the therapies targeting those mutations. Controversial issues in the surgical and radiotherapeutic management of breast cancer will also be discussed and debated. The format will include didactic sessions, question-and-answer panel discussions, and ample time for participant interaction with faculty.

July 21-24, 2011 | Park Hyatt Aviara | Carlsbad, CA 

Overview and Purpose
The 12th International Lung Cancer Congress is designed to provide participants with an update on advances in lung cancer research and therapy, including biology, pathology, screening, staging, personalized therapy, maintenance therapy, novel agents, and ongoing research in Cooperative Groups. Bringing key data from international oncology conferences to participants, the congress will emphasize the importance of personalized therapy and address other current topics of interest. State-of-the-art treatment for early-stage locally advanced and metastatic lung cancer will be discussed. In addition to non–small-cell lung cancer (NSCLC), the congress will address therapy for small-cell lung cancer (SCLC) and mesothelioma. A regular feature of the International Lung Cancer Congress is an update of research efforts from major Cooperative Groups from the United States, Europe, and Asia. The format of the meeting will include didactic lectures from internationally renowned leaders, debates and discussions on controversial topics, extensive panel discussions with case scenarios, multidisciplinary tumor boards, question-and-answer sessions, and afternoon translational workshops focusing on future strategies in development for the treatment of lung cancer.